Olivier KR - Search Results

1

Pseudoprogression after stereotactic body radiotherapy.

Frechette KM, Brown LC, Aubry MC, Wigle DA, Olivier KR. Frechette KM, et al. Among authors: olivier kr. J Thorac Oncol. 2014 Apr;9(4):e29-30. doi: 10.1097/JTO.0000000000000067. J Thorac Oncol. 2014. PMID: 24736086 Free article. No abstract available.

2

Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions.

Stauder MC, Macdonald OK, Olivier KR, Call JA, Lafata K, Mayo CS, Miller RC, Brown PD, Bauer HJ, Garces YI. Stauder MC, et al. Among authors: olivier kr. Radiother Oncol. 2011 May;99(2):166-71. doi: 10.1016/j.radonc.2011.04.002. Epub 2011 May 14. Radiother Oncol. 2011. PMID: 21571384

3

Clinical outcomes and dosimetric considerations using stereotactic body radiotherapy for abdominopelvic tumors.

Barney BM, Olivier KR, Macdonald OK, Fong de Los Santos LE, Miller RC, Haddock MG. Barney BM, et al. Among authors: olivier kr. Am J Clin Oncol. 2012 Dec;35(6):537-42. doi: 10.1097/COC.0b013e31821f876a. Am J Clin Oncol. 2012. PMID: 21659830

4

Stereotactic body radiation therapy in spinal metastases.

Ahmed KA, Stauder MC, Miller RC, Bauer HJ, Rose PS, Olivier KR, Brown PD, Brinkmann DH, Laack NN. Ahmed KA, et al. Among authors: olivier kr. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):e803-9. doi: 10.1016/j.ijrobp.2011.11.036. Epub 2012 Feb 11. Int J Radiat Oncol Biol Phys. 2012. PMID: 22330988

5

Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for advanced cholangiocarcinoma.

Barney BM, Olivier KR, Miller RC, Haddock MG. Barney BM, et al. Among authors: olivier kr. Radiat Oncol. 2012 May 3;7:67. doi: 10.1186/1748-717X-7-67. Radiat Oncol. 2012. PMID: 22553982 Free PMC article.

6

Stereotactic body radiotherapy in the treatment of adrenal metastases.

Ahmed KA, Barney BM, Macdonald OK, Miller RC, Garces YI, Laack NN, Haddock MG, Foote RL, Olivier KR. Ahmed KA, et al. Among authors: olivier kr. Am J Clin Oncol. 2013 Oct;36(5):509-13. doi: 10.1097/COC.0b013e3182569189. Am J Clin Oncol. 2013. PMID: 22781389

7

Stage IIIA non-small cell lung cancer: morbidity and mortality of three distinct multimodality regimens.

Seder CW, Allen MS, Cassivi SD, Deschamps C, Nichols FC, Olivier KR, Shen KR, Wigle DA. Seder CW, et al. Among authors: olivier kr. Ann Thorac Surg. 2013 May;95(5):1708-16. doi: 10.1016/j.athoracsur.2013.02.041. Epub 2013 Mar 29. Ann Thorac Surg. 2013. PMID: 23545194

8

Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT).

Barney BM, Markovic SN, Laack NN, Miller RC, Sarkaria JN, Macdonald OK, Bauer HJ, Olivier KR. Barney BM, et al. Among authors: olivier kr. Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):73-80. doi: 10.1016/j.ijrobp.2013.05.012. Int J Radiat Oncol Biol Phys. 2013. PMID: 23920388

9

Analysis of automatic match results for cone-beam computed tomography localization of conventionally fractionated lung tumors.

Grams MP, Brown LC, Brinkmann DH, Pafundi DH, Mundy DW, Garces YI, Park SS, Olivier KR, de los Santos LE. Grams MP, et al. Among authors: olivier kr. Pract Radiat Oncol. 2014 Jan-Feb;4(1):35-42. doi: 10.1016/j.prro.2013.02.008. Epub 2013 Mar 26. Pract Radiat Oncol. 2014. PMID: 24621421

10

Feasibility of proton transmission-beam stereotactic ablative radiotherapy versus photon stereotactic ablative radiotherapy for lung tumors: a dosimetric and feasibility study.

Mou B, Beltran CJ, Park SS, Olivier KR, Furutani KM. Mou B, et al. Among authors: olivier kr. PLoS One. 2014 Jun 2;9(6):e98621. doi: 10.1371/journal.pone.0098621. eCollection 2014. PLoS One. 2014. PMID: 24887068 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page